Aurum Biosciences

A biopharmaceutical company developing novel oxygen carriers and proprietary software for use with MRI, initially for Acute Ischaemic Stroke.

placeGlasgow, Scotland, United Kingdom calendar_todayFounded 2015 groups6 employees language aurumbiosciences.com

Registered entities

Social engagement

Social engagement: 887 social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

39 investors on record; lead investors include Tricapital, InnoScot, Infinion BioPharma, Scottish Investment Bank.

Investor typeCountShare
Private equity13%
Angel & family office13%
Other / undisclosed3795%

Recent activity

25 May 2026
Event
UK Biotech Day
3 Mar 2026
Event
COG UK
26 Nov 2025
Event
webinar on climate change effects on stroke incidence
Coming soon